研究报告 |
|
|
|
|
人HPPCn重组蛋白可溶性表达及其增殖活性检测 |
路青山1, 乔媛媛2, 李金凤3, 王运良3, 王姗姗3, 史成和2, 杨霄鹏1, 张达矜2 |
1. 郑州大学第二附属医院 郑州 450014;
2. 中国人民解放军海军总医院基础医学研究中心 北京 100048;
3. 中国人民解放军第148医院 淄博 255300 |
|
Soluble Expression of Human HPPCn Recombinant Protein and Detection of Its Proliferation Activity |
LU Qing-shan1, QIAO Yuan-yuan2, LI Jin-feng3, WANG Yun-liang3, WANG Shan-shan3, SHI Cheng-he2, YANG Xiao-peng1, ZHANG Da-jin2 |
1. Department of Neurology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou 450001, China;
2. Center for Basic Medical Sciences, Navy General Hospital of Chinese PLA, Beijing 100048, China;
3. The 148th Hospital of Chinese PLA, Zibo 255300, China |
引用本文:
路青山, 乔媛媛, 李金凤, 王运良, 王姗姗, 史成和, 杨霄鹏, 张达矜. 人HPPCn重组蛋白可溶性表达及其增殖活性检测[J]. 中国生物工程杂志, 2015, 35(12): 15-20.
LU Qing-shan, QIAO Yuan-yuan, LI Jin-feng, WANG Yun-liang, WANG Shan-shan, SHI Cheng-he, YANG Xiao-peng, ZHANG Da-jin. Soluble Expression of Human HPPCn Recombinant Protein and Detection of Its Proliferation Activity. China Biotechnology, 2015, 35(12): 15-20.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.20151203
或
https://manu60.magtech.com.cn/biotech/CN/Y2015/V35/I12/15
|
[1] LaBrecque D R, Pesch L A. Preparation and partial characterization of hepatic regenerative stimulator substance (SS) from rat liver. J Physiol, 1975, 248(2):273-284.
[2] Cui C P, Zhang D J, Shi B X, et al. Isolation and functional identification of a novel human hepatic growth factor:Hepatopoietin Cn+. Hepatology, 2008, 47(3):986-995.
[3] Matsuoka K, Taoka M, Satozawa N, et al. A nuclear factor containing the leucine-rich repeats expressed in murine cerebellar neurons. Proc Natl Acad Sci U S A, 1994, 91(21):9670-9674.
[4] Adegbola O, Pasternack G R. Phosphorylated retinoblastoma protein complexes with pp32 and inhibits pp32-mediated apoptosis. J Biol Chem, 2005, 280(16):15497-15502.
[5] 魏苹,杜劭君,崔春萍,等.新的肝细胞生长因子HPPCn的表达、纯化及体外活性检测.中国生物工程杂志, 2007, 27(10):6-11. Wei P, Du S J, Cui C P, et al. Expression, purification and activity detection of the new hepatocyte growth factor HPPCn. China Biotechnology, 2007, 27(10):6-11.
[6] Thomas J G, Ayling A, Baneyx F. Molecular chaperones, folding catalysts, and the recovery of active recombinant proteins from E. Coli. To fold or to refold. Appl Biochem Biotechnol, 1997, 66(3):197-238.
[7] Qing G, Ma L, Khorchid A, et al. Cold-shock induced high-yield protein production in Escherichia coli. Nat Biotechnol, 2004, 22(7):877-882.
[8] Benoit R M, Wilhelm R N, Scherer-Becker D, et al. An improved method for fast, robust, and seamless integration of DNA fragments into multiple plasmids. Protein Expr Purif, 2006, 45(1):66-71.
[9] Chen J H, Zhang T, Ju C, et al. An integrated immunoproteomics and bioinformatics approach for the analysis of Schistosoma japonicum tegument proteins. J Proteomics, 2014, 98:289-299.
[10] Lu Q. Seamless cloning and gene fusion. Trends Biotechnol, 2005, 23(4):199-207.
[11] Derman A I, Prinz W A, Belin D, et al. Mutations that allow disulfide bond formation in the cytoplasm of Escherichia coli. Science, 1993, 262(5140):1744-1747.
[12] Ellis R J. The molecular chaperone concept. Semin Cell Biol, 1990, 1(1):1-9.
[13] Vasina J A, Baneyx F. Expression of aggregation-prone recombinant proteins at low temperatures:A comparative study of the Escherichia coli cspA and tac promoter systems. Protein Expr Purif, 1997, 9(2):211-218.
[14] 张达矜,崔春萍,乔媛媛,等.新的肝细胞生长因子HPPCn的人多组织表达谱分析.军事医学科学院院刊, 2010, 34(06):505-508. Zhang D J, Cui C P, Qiao Y Y, et al. Human multiple tissue expression profile analysis of new hepatocyte growth factor HPPCn. Bulletin of the Academy of Military Medical Sciences, 2010, 34(06):505-508.
[15] Cui C P, Wei P, Liu Y, et al. The protective role of Hepatopoietin Cn on liver injury induced by carbon tetrachloride in rats. Hepatol Res, 2009, 39(2):200-206.
[16] Liu Y, Saiyan S Y, Men T Y, et al. Hepatopoietin Cn reduces ethanol-induced hepatoxicity via sphingosine kinase 1 and sphingosine 1-phosphate receptors. J Pathol, 2013, 230(4):365-376.
[17] Chang J, Liu Y, Zhang D D, et al. Hepatopoietin Cn suppresses apoptosis of human hepatocellular carcinoma cells by up-regulating myeloid cell leukemia-1. World J Gastroenterol, 2010, 16(2):193-200.
[18] Wang S S, Wang Y L, Lu Q S, et al. The expression and distributions of ANP32A in the developing brain. Biomed Res Int, 2015, 2015:207347. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|